Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
STAAR Surgical
NasdaqGM:STAA Community
Create a narrative
STAAR Surgical
Undervalued
Overvalued
STAAR Surgical
WA
Analyst Price Target
Consensus Narrative from 10 Analysts
New Experience Center And Training Investments May Drive Future ICL Adoption
Key Takeaways Opening of the new experience center and investments in training may boost ICL adoption, expanding market share and enhancing revenue growth. Strong sales in EMEA and anticipated technology advancements indicate sustained revenue growth potential and improved earnings through increased demand.
View narrative
US$40.68
FV
46.2% undervalued
intrinsic discount
14.40%
Revenue growth p.a.
Set as Fair Value
2
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
14 days ago
author updated this narrative
Your Valuation for
STAA
STAAR Surgical
Your Fair Value
US$
Current Price
US$21.88
21.5% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-13m
633m
2015
2018
2021
2024
2025
2027
2030
Revenue US$632.6m
Earnings US$40.4m
Advanced
Set as Fair Value